| |
Initiated rituximab before remission |
Initiated rituximab afterremission |
| The number of patients |
11 |
16 |
| The median age of the patients (years) |
38 (25-70) |
37.5 (22-70) |
| The median hemoglobin (g/L) |
87 (53-110) |
75 (35-109) |
| The median platelet (x109/L) |
7 (3-37) |
11 (2-51) |
| The median LDH |
825 (450-2031) |
1011.5 (379-2524) |
| The median time of platelets recovery |
15.5 (7-33) |
16 (3-35) |
| The median time of ADAMTS13 recovery |
24 (14-78) |
25 (13-78) |
| The median time of hospital stay |
27 (10-42) |
28.5 (11-39) |
| Number of patients who relapsed |
0 |
0 |
| Adverse effects |
1 (9.0%) |
3 (18.8%) |
